Overview
Throughout my career, I have focused on the relationship of cerebral aging to affective and cognitive functions in middle-aged and older adults. Since joining Weill Cornell’s Institute of Geriatric Psychiatry in 2004, I have combined my background as a clinical neuropsychologist with my expertise in cognitive neuroscience to develop and conduct a program of research studies using MRI to examine neurobiological predictors of expression, course, and outcomes of depression. My studies use performance-based measures and multimodal neuroimaging (task-based fMRI, resting state fMRI and diffusion tensor imaging) to examine functioning of brain networks (e.g., cognitive control dysfunction, reward abnormalities) and treatment response.
I currently hold an NIMH-funded R01 that uses task-based fMRI and probabilistic tractography to better understand the role of cognitive control, affective networks, and reward networks in antidepressant response of late-life depression. In addition, I am using multimodal neuroimaging (task-based fMRI and diffusion tensor imaging) to better understand target engagement of neurobiologically-informed psychosocial interventions for MDD (e.g., Engage versus Problem-Solving Therapy (PST); Cognitive remediation delivered via mobile technology, Project EVO(1R61MH110509)).
As Vice Chair of Psychology at Weill Cornell Medicine and the Director of the Institute's Training Unit, I play an integral role in mentoring clinical scientists at the postdoctoral fellow and junior faculty level both at Weill Cornell and through national mentoring programs.
Highlights
- 1Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
- 2Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
- 3Translational psychiatry · 2021
Publications
Funding
Active
11 grants- Sub-PIR25MH112484-07Research Career Institute in Mental Health of Aging (CIMA)National Institute of Mental Health · 2017–2030 · via University of Vermont· 2 renewals
- Sub-PIR01MH136161-03A transdiagnostic study of emotional impulsivity in suicidal ideation and behaviorNational Institute of Mental Health · 2024–2029 · via New York University
- Co-IR01MH134006-01A1Emotion Reactivity, Cognitive Reappraisal, and Suicidal Ideation In Middle-aged and Older Adults at High Suicide RiskNational Institute of Mental Health · 2024–2029
- Sub-PIU01MH136059-02JOSH-MH: Jointly Observed Scalable Hypotheses for Mental HealthNational Institute of Mental Health · 2024–2029 · via The General Hospital Corporation (dba Massachusetts General Hospital)
- Co-IR01MH133953-01Target Engagement During Social Reward Psychotherapy for Mid- and Late-Life Suicidality: A Precision Imaging TrialNational Institute of Mental Health · 2023–2028
- Co-IR61MH128516-02A Mobile Intervention for Suicide Prevention For Middle-aged And Older Adults After a Suicide-Related HospitalizationNational Institute of Mental Health · 2022–2027
- MPIT32MH019132-35Research Fellowship in Geriatric Mood DisordersNational Institute of Mental Health · 2021–2027
- Co-IP30AG073105-05Scalable subtyping and dynamic tracking of social disconnection in older adultsNational Institute on Aging · 2025–2027 · via University of Pennsylvania
- MPIR01MH118388-05Efficacy of biomarker-guided rTMS for treatment resistant depressionNational Institute of Mental Health · 2019–2027
- Sub-PIR01MH124110-05Remote computational phenotyping of behavioral and affective dynamics in major depressionNational Institute of Mental Health · 2020–2026 · via Yale University
- Sub-PIR33MH122464-05Nicotinic modulation of the cognitive control system in late-life depressionNational Institute of Mental Health · 2022–2025 · via Vanderbilt University Medical Center
Completed grants (11)
- Sub-PIR01MH124381-05Brain-based Mechanisms of Emotion Regulation in Aging and Mood DisordersNational Institute of Mental Health · 2020–2025 · via The Brigham & Women's Hospital INC
- Co-IP50MH113838-01ALACRITY for Late- and Mid-Life Mood DisordersNational Institute of Mental Health · 2017–2024
- Sub-PIR61MH122464-02Nicotinic modulation of the cognitive control system in late-life depressionNational Institute of Mental Health · 2020–2023 · via Vanderbilt University Medical Center
- PIR33MH110509-05A Computerized Intervention Targeting Cognitive Control Network Deficits in DepressionNIMH · 2016–2022 · via NIH RePORTER
- Sub-PIR61MH110509-02Computerized Intervention Targeting Cognitive Control Network Deficits in DepressionNational Institute of Mental Health · 2016–2022 · via University of Washington, The
- KPF32MH120989-01Targeting salience network dysfunction in depression with individualized brain network mapping and TMSNational Institute of Mental Health · 2019–2022
- Co-IR56MH114976-01A1Diagnostic Neuroimaging Biomarkers of Dysfunctional Valence Systems in Depression and AnxietyNational Institute of Mental Health · 2018–2019
- PIR01MH097735-04White Matter and Emotional and Cognitive Control in Late-Onset DepressionNational Institute of Mental Health · 2012–2019
- Sub-PIR21MH110110-02Aiding Decision-Making and Trial Design Using Multivariate Network Meta-AnalysisNational Institute of Mental Health · 2016–2018 · via University of Texas, Houston
- MPIR01MH099167-04 EWEffects of Maintenance Treatment with Olanzapine vs. Placebo on Brain StructureNational Institute of Mental Health · 2012–2017 · via Centre for Addiction & Mental Health
- PIK23MH074818-05ANTERIOR CINGULATE ACTIVATION IN GERIATRIC DEPRESSIONNIMH · 2005–2011 · via NIH RePORTER
Clinical research
Active
1 study- PIA Transdiagnostic Study of Emotional Impulsivity in Suicidal Ideation and BehaviorNYU Langone · OPEN TO ACCRUAL (as of 2025)
Completed & closed trials (2)
- PIBrain-based Mechanisms of Emotion Regulation in Aging and Mood DisordersNational Institute of Mental Health · CLOSED TO ACCRUAL (as of 2025)
- PINCT04843930Improving Cognitive Health in COVID-19 Survivors Through Digital TherapeuticsPHASE2 · Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2025)Cognitive Dysfunction; Covid19
News mentions
- Brain Imaging May Identify Patients Likely to Benefit from Anxiety Care AppJuly 31, 2025
By understanding differences in how people’s brains are wired, clinicians may be able to predict who would benefit from a self-guided anxiety care app, according to a new analysis from a clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
- Cognitive Behavioral Therapy App Improves Anxiety in Young AdultsAugust 20, 2024
Researchers at Weill Cornell Medicine and NewYork-Presbyterian found that a self-guided cognitive behavioral therapy (CBT) app, called Maya, significantly reduced anxiety in young adults struggling with mental health challenges.
- Digital Domains: Apps, Video Games and Other Media are Filling Gaps in Mental HealthcareJanuary 14, 2020
Apps, video games and other media are filling gaps in mental healthcare
Mentoring
- RDRaura Doreste-MendezPostdoc mentee · 2021–2023
- AWAshley WuMD mentee · Class of 2021
- LJLu JinMD mentee · Class of 2020
External relationships
Advisory/Scientific Board Member
American Medical Association
Other Interest
American Medical Association